Key facts
- This page summarizes Christopher Scott Hill's Form 4 filing for Core Laboratories Inc. /DE/ (CLB).
- 3 reported transactions and 1 derivative row are listed below.
- Accepted by SEC: 03 Jan 2024, 17:43.
Christopher Scott Hill - 31 Dec 2023 Form 4 Insider Report for Core Laboratories Inc. /DE/ (CLB)
- Reporting relationship
- SVP & CFO
- Issuer ticker
- CLB
- Reported as of
- 31 Dec 2023
- Net transaction value
- -$244,944
- SEC form
- 4
- Accepted by SEC
- 03 Jan 2024, 17:43:16 UTC
- Prior SEC filing
- 21 Feb 2023
- Next SEC filing
- 15 Feb 2024
- Source filing
- View source filing
- Reporting owner signature
- /s/ Mark Tattoli, Attorney-in-Fact
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Christopher Scott Hill filed Form 4 for Core Laboratories Inc. /DE/ (CLB) on 03 Jan 2024.
Change
- Previous filing in this sequence was filed on 21 Feb 2023.
- Current net transaction value: -$244,944.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
CLB
transaction
Common Stock
Tax liability
- Transaction value
- $244,944
- Shares
- -13,870
- Change %
- -16%
- Price
- $17.66
- Shares after
- 72,374
- Date
- 31 Dec 2023
- Ownership
- Direct
CLB
transaction
Common Stock
Options Exercise
- Transaction value
- $0
- Shares
- +36,072
- Change %
- +72%
- Price
- $0.000000
- Shares after
- 86,244
- Date
- 31 Dec 2023
- Ownership
- Direct
CLB
holding
Common Stock
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 59
- Date
- 31 Dec 2023
- Ownership
- 401(k) Plan
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
CLB
transaction
Derivative
Performance Shares
Options Exercise
- Transaction value
- $0
- Shares
- -36,072
- Change %
- -100%
- Price
- $0.000000*
- Shares after
- 0
- Date
- 31 Dec 2023
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 36,072
- Exercise price
- $0.000000
- Footnotes
- F1
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 1 footnote
Footnote F1
These shares were awarded as restricted performance shares in February 2021, as disclosed in the Reporting Person's Form 4 filing on February 19, 2021. The Company finished in the 81st percentile of return on invested capital among the Bloomberg Peer Group at the conclusion of the performance period on December 31, 2023. Excess shares that could vest above the 75th percentile are subject to an absolute total shareholder return modifier, which was negative over the relevant performance period, thereby reducing the number of such shares eligible to vest by one-half. Therefore, the performance criteria and requirements for vesting have been satisfied at 106.25% of the target award level, and such number of shares vested on December 31, 2023.